[Huajian Medical Adjusts Strategy, Applies for U.S. Stablecoin License and Plans Fundraising to Increase Reserves] Huajian Medical (1931) announced an adjustment to its business strategy, suspending its previously planned cryptocurrency acquisition of no more than 3 billion yuan and canceling the transaction to acquire a 20.31% stake in Guofu Quantum (0290) for 3.142 billion yuan. The company stated that it will disclose Ethereum (ETH) transaction details in accordance with listing rules, while it has initiated the process of applying for a U.S. stablecoin license and plans to raise funds to increase its U.S. dollar reserves. Huajian Medical will also simultaneously advance the development of its AI algorithm platform, integrating its distribution network with the RWA platform to optimize the accuracy of its asset valuation model.